Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Targeted Medical Pharma, Inc. | v320832_ex31-2.htm |
| 10-Q - FORM 10-Q - Targeted Medical Pharma, Inc. | v320832_10q.htm |
| EX-10.3 - EXHIBIT 10.3 - Targeted Medical Pharma, Inc. | v320832_ex10-3.htm |
| EX-10.1 - EXHIBIT 10.1 - Targeted Medical Pharma, Inc. | v320832_ex10-1.htm |
| EX-10.5 - EXHIBIT 10.5 - Targeted Medical Pharma, Inc. | v320832_ex10-5.htm |
| EX-10.2 - EXHIBIT 10.2 - Targeted Medical Pharma, Inc. | v320832_ex10-2.htm |
| EX-10.4 - EXHIBIT 10.4 - Targeted Medical Pharma, Inc. | v320832_ex10-4.htm |
| EX-31.1 - EXHIBIT 31.1 - Targeted Medical Pharma, Inc. | v320832_ex31-1.htm |
Exhibit 32.1
CERTIFICATION
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Targeted Medical Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended June 30, 2012 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: August 14, 2012 | By: | /s/ William E. Shell, MD |
|
William E. Shell, MD Principal Executive Officer | ||
| By: | /s/ Ronald W. Rudolph | |
| Ronald W. Rudolph | ||
| Principal Financial Officer |